HMC Capital Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

HMC Capital yıllık ortalama 52.8% oranında kazançlarını artırırken, Capital Markets sektöründe kazançlar growing at 6.8% annual. Gelirler growing yılda ortalama 12.6% oranında artmaktadır. HMC Capital'in özkaynak karlılığı 7.6% ve net marjı 70.4%'dir.

Anahtar bilgiler

52.8%

Kazanç büyüme oranı

55.9%

EPS büyüme oranı

Capital Markets Sektör Büyümesi	6.6%
Gelir büyüme oranı	12.6%
Özkaynak getirisi	7.6%
Net Marj	70.4%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

HMC Capital nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

CHIA:HMC Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	94	66	61
31 Mar 24	88	61	60
31 Dec 23	82	55	36
30 Sep 23	85	56	32
30 Jun 23	87	57	49
31 Mar 23	110	53	42
31 Dec 22	132	49	35
30 Sep 22	149	63	28
30 Jun 22	167	77	22
31 Mar 22	146	35	19
31 Dec 21	125	-7	15
30 Sep 21	102	-53	13
30 Jun 21	79	-100	11
31 Mar 21	72	-68	10
31 Dec 20	66	-36	9
30 Sep 20	64	-15	8
30 Jun 20	62	6	8
31 Mar 20	60	-8	9
31 Dec 19	57	-21	9
30 Sep 19	53	-22	9
30 Jun 19	49	-23	8

Kaliteli Kazançlar: HMC yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: HMC 'nin mevcut net kar marjları (70.4%) geçen yılın (65.3%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: HMC son 5 yılda karlı hale geldi ve kazançlarını yıllık 52.8% oranında artırdı.

Büyüme Hızlandırma: HMC 'un son bir yıldaki kazanç büyümesi ( 15.6% ) 5 yıllık ortalamasının ( 52.8% /yıl) altındadır.

Kazançlar vs. Sektör: HMC geçen yılki kazanç büyümesi ( 15.6% ) Capital Markets sektörünün 15.6% değerini aştı.

Özkaynak Getirisi

Yüksek ROE: HMC 'nin Özsermaye Getirisi ( 7.6% ) düşük olarak değerlendiriliyor.

HMC Capital Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: EPS: AU$0.19 (vs AU$0.18 in FY 2023)

HMC Capital Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

First half 2024 earnings released: FFO per share: AU$0.2 (vs AU$0.084 in 1H 2023)

HMC Capital Limited to Report First Half, 2024 Results on Feb 20, 2024

Full year 2023 earnings released: EPS: AU$0.18 (vs AU$0.26 in FY 2022)

HMC Capital Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

Recent updates

HMC Capital Limited (ASX:HMC) completed the acquisition of Global Switch Australia Holdings Pty Limited from Global Switch Holdings Limited.

HMC Capital Limited (ASX:HMC) completed the acquisition of Global Switch Australia Holdings Pty Limited from Global Switch Holdings Limited.

HMC Capital Limited (ASX:HMC) agreed to acquire iseek Pty Ltd. for AUD 400 million.

HMC Capital Limited (ASX:HMC) entered into an agreement to acquire Global Switch Australia Holdings Pty Limited from Global Switch Holdings Limited for AUD 2.1 billion.

HMC Capital Limited has completed a Follow-on Equity Offering in the amount of AUD 300.000006 million.

HMC Capital Limited has filed a Follow-on Equity Offering in the amount of AUD 300.000006 million.

HMC Capital Limited, Annual General Meeting, Nov 27, 2024

HMC Capital Limited (ASX:HMC) acquired Market Central Lutwyche from Abacus Group (ASX:ABG) and ISPT Retail Australia Property Trust managed by ISPT Pty Ltd for approximately AUD 120 million.

Final dividend of AU$0.06 announced

HMC Capital Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2024, Payable on October 2, 2024

Full year 2024 earnings released: EPS: AU$0.19 (vs AU$0.18 in FY 2023)

HMC Capital Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

HMC Capital Limited (ASX:HMC) completed the acquisition of Payton Capital Ltd

New minor risk - Shareholder dilution

HMC Capital Limited has completed a Follow-on Equity Offering in the amount of AUD 100.000004 million.

HMC Capital Limited has filed a Follow-on Equity Offering in the amount of AUD 30.000003 million.

Now 20% undervalued

First half dividend of AU$0.06 announced

First half 2024 earnings released: FFO per share: AU$0.2 (vs AU$0.084 in 1H 2023)

HMC Capital Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 18%

Insufficient new directors

Now 20% undervalued after recent price drop

HMC Capital Limited (ASX:HMC) and HealthCo Healthcare and Wellness REIT (ASX:HCW) completed the acquisition of Healthscope Portfolio from Medical Properties Trust, Inc. (NYSE:MPW).

HMC Capital Limited, Annual General Meeting, Nov 15, 2023

Now 20% undervalued

HMC Capital Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on October 4, 2023

Full year 2023 earnings released: EPS: AU$0.18 (vs AU$0.26 in FY 2022)

HMC Capital Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

Independent Non-Executive Director recently bought AU$250k worth of stock

First half 2023 earnings released: FFO per share: AU$0.08 (vs AU$0.10 in 1H 2022)

Now 21% undervalued

HMC Capital Limited to Report First Half, 2023 Results on Feb 23, 2023

Home Consortium Limited Announces Board Changes

Insufficient new directors

Home Consortium Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings released: EPS: AU$0.26 (vs AU$0.37 loss in FY 2021)

Home Consortium Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Home Consortium Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Home Consortium Limited's wholly owned subsidiary HMC Investment Management Limited Launches HMC Capital Partners Fund 1

High number of new and inexperienced directors

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Home Consortium Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 7, 2022

Home Consortium Limited (ASX:HMC) agreed to acquire Aventus Group (ASX:AVN).

Home Consortium Limited to Report First Half, 2022 Results on Feb 24, 2022

Now 20% undervalued after recent price drop

MD, CEO & Director recently bought AU$501k worth of stock

High number of new and inexperienced directors

Key Executive recently bought AU$151k worth of stock

Independent Non-Executive Director recently bought AU$125k worth of stock

Full year 2021 earnings released

Home Consortium Limited (ASX:HMC) acquired portfolio of 8 private oncology assets from Genesis Care Pty Ltd for approximately AUD 110 million.

Forecast breakeven pushed back to 2022

Home Consortium Limited (ASX:HMC) entered into an agreement to acquire Five Dock (Childcare), NSW for AUD 13.1 million.

Home Consortium Limited Reaffirms FFO Guidance for the Fiscal Year 2021

Revenue beats expectations

First half 2021 earnings released: FFO AU$0.082 per share (vs AU$0.075 loss in 1H 2020)

New 90-day low: AU$3.76

Home Consortium Limited to Report First Half, 2021 Results on Feb 24, 2021

Home Consortium Limited (ASX:HMC) agreed to acquire Portfolio of 6 health, education and Government services properties for approximately AUD 130 million.

New 90-day high: AU$4.24

Home Consortium Limited Elects Kelly Odwyer as Director

New 90-day high: AU$3.63

Christopher Saxon to Assume the Role of Independent Chairman of Home Consortium Limited from 1 January 2021

New 90-day high: AU$3.44

Home Consortium Limited (ASX:HMC) signed binding contract to acquire Glenmore Park Town Centre in Australia for AUD 150 million.

Home Consortium Limited Announces Executive Appointments

New 90-day high: AU$3.25

New 90-day high - AU$3.23